How does Feihe International Inc. operate its premium-focused infant formula business and what drives its margins?
Feihe International Inc. shifted from mass to premium formulas, leveraging a localized supply chain, strong offline retail, and brand trust to hold over 20% market share in 2025; this matters as it shows resilience amid China's low birthrate and rising domestic competition.
Track product mix, channel expansion, and pricing power; a focus on premium SKUs and trust-building – see Feihe BCG Matrix Analysis – drives higher gross margins and repeat purchases.
What Does Feihe Actually Sell?
Feihe International Inc. sells high-end and ultra-premium milk powders, led by infant formulas formulated to mirror Chinese breast milk, plus expanding adult nutrition powders for seniors and metabolic health; customers pay for food safety, localized freshness, and scientific nutrition claims.
Core product lines
Feihe infant formula ranges from stage-based Asteps and Starry Bright infant formulas to specialty toddler and follow – on SKUs; the company also sells senior-targeted milk powders and functional dairy for metabolic health. In fiscal 2025, infant formula accounted for roughly ~82% of revenue, per audited segment disclosures.
Main customer groups
Primary buyers are urban Chinese parents purchasing premium baby formula through supermarkets, specialty baby stores, and online platforms (Tmall, JD.com); a growing cohort of older consumers buys senior nutrition powders through pharmacies and e-commerce. Institutional buyers include retailers and distributors across China.
Value customers receive
Customers pay for perceived higher food safety, localized R&D matching Chinese breast – milk profiles, and faster farm – to – can freshness enabled by domestic plants; this supports premium pricing – average selling price for core infant SKUs rose ~6 – 8% in 2025 versus 2024.
Why the offering stands out
Feihe business model emphasizes local manufacturing and tight Feihe supply chain control to shorten turnaround versus imported brands, plus targeted Feihe marketing strategy (celebrity endorsements, livestream commerce) and strong shelf presence – domestic production supported ~90% of formula sales in 2025. See more on corporate ownership in this article: Ownership and Control of Feihe Company
Feihe SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Does Feihe Run Its Business Day to Day?
Feihe International Inc. runs day-to-day on a vertically integrated two-hour industrial circle in Heilongjiang: milk is collected from company-managed pastures and herds, transported to nearby plants, and processed into powder within hours; sales are driven by an extensive offline distribution and face-to-face marketing network that converts product into retail sales across China.
Operating model: vertical control and speed
Feihe Company centralizes herd management, logistics, and processing inside a two-hour industrial circle to minimize farm-to-factory time. Daily ops prioritize raw-milk quality checks, rapid chilling, and immediate transfer to spray-drying lines to protect nutrients and safety.
Product delivery: fast processing to retail shelves
Feihe infant formula is sold through a mix of offline retail counters, workshops, and online platforms; customers buy at >100,000 retail points or via e-commerce partners, with inventory replenished from regional warehouses daily.
Production and sourcing: owned pastures and high-yield herds
The company owns and operates pastures and dairy herds in Heilongjiang, implementing herd health programs and genetic selection to sustain high-yield raw milk; on-site labs run routine microbiological and compositional assays before processing.
Sales channels: face-to-face plus omnichannel
Field teams coordinate tens of thousands of offline seminars and mother-and-baby workshops annually, supplementing sales on Tmall and JD.com; this ground marketing builds advocacy and reduces reliance on mass advertising – see the company sales playbook in Sales and Marketing Strategy of Feihe Company.
Key assets and systems: processing, QA, and distribution
Core assets include spray-drying plants, on-site QC labs, refrigerated logistics, and a CRM-driven field-sales platform; partnerships with national distributors and local retailers support last-mile coverage to over 100,000 retail touchpoints.
What makes it work: speed, trust, and direct engagement
Processing milk into powder within hours preserves quality and underpins Feihe business model advantages; direct workshops and face-to-face outreach convert trust into repeat purchases, supporting predictable Feihe revenue streams and strong retail sell-through.
Feihe Business Model Canvas
- One-time Payment
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
How Does Revenue Flow Through Feihe?
Revenue flows into Feihe International Inc. mainly through a high-margin wholesale-to-retail model where distributor orders convert demand into cash before shipment; infant formula makes up most sales while adult nutrition is growing. Payments are typically collected up front from a network of >2,000 distributors, turning channel demand into immediate revenue.
Main revenue source: wholesale infant formula
Feihe Company earns most revenue from premium Feihe infant formula sold to over 2,000 distributors who supply mother-and-baby stores, supermarkets, and marketplaces. This channel-focused Feihe business model yields a high gross margin – about 64 percent in fiscal 2025 – because formulas carry premium pricing and cost-efficient manufacturing.
Additional streams: adult nutrition and e-commerce
Secondary Feihe revenue streams include adult nutrition products and online sales via platforms and brand stores; e-commerce and direct-to-consumer channels support margin preservation and product mix diversification. The company is shifting mix: infant formula was ~85 percent of revenues in 2025 while adult nutrition is expected to drive incremental growth in 2026.
Pricing and monetization: premium wholesale pricing
Feihe monetizes through upfront wholesale sales at premium prices for specialized formulas and value-added adult products; cash collection often precedes shipment, making the model highly cash-efficient. There are limited recurring subscription programs; most revenue is transactional via distributor purchase orders.
Primary revenue drivers: channel reach and pricing power
Revenue is driven most by distributor reach, premium pricing of Feihe infant formula, and brand trust that supports shelf placement and online conversion. Scale in manufacturing, quality controls, and partnerships with Chinese retailers boost volume; expanding adult nutrition products should increase revenue diversification in 2026. Read more in this company overview: History and Background of Feihe Company
Feihe Marketing Mix
- Complete Marketing Mix Analysis
- Effortlessly Communicate Your Business Strategy
- Investor-Ready Format
- 100% Editable and Customizable
- Clear and Structured Layout
What Makes Feihe's Model Sustainable or Fragile?
Feihe Company's model rests on deep premium-brand equity and a dominant 21.5 percent share of China's infant-formula market, which supports pricing power; but it is fragile because China's births dropped to about 9,000,000 in 2025, shrinking the total addressable market and forcing higher dependence on premiumization and functional ingredients for revenue growth.
Brand-led premium moat
Feihe infant formula benefits from strong brand trust and premium positioning that reduce exposure to price wars and protect gross margins, which supported reported 2025 revenue resilience across channels.
Scale and channel control
Scale in domestic manufacturing, broad distribution on Tmall and JD.com, plus owned offline ties with supermarkets and pharmacies, sustain efficient Feihe supply chain and Feihe e-commerce and direct-to-consumer strategy execution.
Demographic dependency
With births near 9,000,000 in 2025, Feihe revenue streams face a shrinking base; the firm depends on higher ARPU via additives like HMOs and on expanding into adult and elderly nutrition to offset fewer infants.
Resilience vs. maturation
Feihe business model appears resilient in 2025 due to market share and pricing power, but fragile long-term: valuation hinges on successful pivot to total nutrition for China's aging population and sustained R&D investment in product innovation. Read more in Growth Outlook of Feihe Company.
Feihe Boston Consulting Group Matrix
- Built by Experts, Trusted by Consultants
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
Related Blogs
- What Is the History of Feihe Company and How Did It Evolve?
- What Is the Competitive Landscape of Feihe Company and How Does It Compete?
- What Is the Growth Outlook of Feihe Company and Where Is It Heading?
- How Does Feihe Company Reach Customers and Turn Demand into Sales?
- What Do the Mission, Vision, and Core Values of Feihe Company Reveal?
- Who Are the Core Customers in Feihe Company's Target Market?
- Who Owns Feihe Company Today and Who Holds Control?
Frequently Asked Questions
Feihe sells high-end and ultra-premium milk powders, led by infant formulas, plus expanding adult nutrition powders for seniors and metabolic health. Its core infant formula lines include stage-based Asteps and Starry Bright products, along with toddler and follow-on SKUs. The business is built around food safety, localized freshness, and scientific nutrition claims.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.